WebOct 22, 2024 · Matthew Kershaw, Chief Executive and Place Based Leader for Health, Croydon Health Services NHS Trust NHS England and NHS Improvement (NHSEI) has made a £250 million Winter Access Fund available to systems from November 2024 to March 2024 to build resilience and improve patient access. WebMar 10, 2024 · In December 2024, NHSEI published a letter setting out temporary GP contract changes to support the COVID-19 vaccination programme, including QOF …
Impact of work schedules of senior resident physicians on patient …
Web1 day ago · Leeds Teaching Hospitals NHS Trust has renewed and extended its contract with specialist UK healthcare informatics provider, Epro. Epro has been a supplier to Leeds Teaching Hospitals Trust (LTHT) since 2011. The five-year contract renewal for Epro’s clinical workflow solutions was agreed in winter 2024, and now includes Epro’s latest ... WebMar 16, 2024 · The guidance confirmed that PCNs will be funded ‘£7.46 per weighted patient’. This represents 2p more than the combined funding for the current £1.44 per head Network Contract DES extended hours funding and the current £6 per head CCG-commissioned extended access services – which are being ‘brought together’ into the … office 2013 rsload
GP contract changes England 2024/23 - British Medical …
WebMar 3, 2024 · Minimum of 30 minutes per 1,000 registered patients per week £1.44 per head CCG-commissioned extended access services: Weekday pre-bookable and same-day appointments in evenings (after 6:30pm) to provide an additional 1.5 hours a day Weekend pre-bookable and same-day appointments on both Saturdays and Sundays to ‘meet … WebApr 11, 2024 · Successful applicants are able to access two benefits of the programme: 1. A training fund of up to £3,000 to support early partnership skills development. Participants select the training they assess they need. Funding of up to £3,000 is available to all eligible participants, regardless of full-time equivalent (FTE). 2. WebExpanded Access. Synonym (s) Compassionate Use. Legal use of an investigational drug outside of a clinical trial to treat a person who has a serious or immediately life … office 2013 release notes